MX2021006716A - Metodos in vitro para la deteccion de enfermedad renal. - Google Patents

Metodos in vitro para la deteccion de enfermedad renal.

Info

Publication number
MX2021006716A
MX2021006716A MX2021006716A MX2021006716A MX2021006716A MX 2021006716 A MX2021006716 A MX 2021006716A MX 2021006716 A MX2021006716 A MX 2021006716A MX 2021006716 A MX2021006716 A MX 2021006716A MX 2021006716 A MX2021006716 A MX 2021006716A
Authority
MX
Mexico
Prior art keywords
kidney disease
methods
disclosure
renal disease
gfr
Prior art date
Application number
MX2021006716A
Other languages
English (en)
Inventor
Mahalakshmi Yerramilli
Murthy V S N Yerramilli
Original Assignee
Idexx Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52628954&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2021006716(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Idexx Lab Inc filed Critical Idexx Lab Inc
Publication of MX2021006716A publication Critical patent/MX2021006716A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a métodos y aparatos para la determinación, diagnóstico, progreso y pronóstico de la enfermedad renal y mortalidad asociada con la enfermedad renal. La descripción incluye un método para determinar la función renal, en particular estimar velocidad de filtración glomerular (GFR), en un animal. La GFR puede ser útil en el diagnóstico y tratamiento de la enfermedad o disfunción renal. En varios aspectos, la descripción se dirige al uso de dimetilarginina simétrica libre (SDMA) y creatinina en muestras de sangre de animales, en particular gatos y perros, para determinar la velocidad de filtración glomerular y enfermedad renal.
MX2021006716A 2013-09-05 2016-03-04 Metodos in vitro para la deteccion de enfermedad renal. MX2021006716A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361874011P 2013-09-05 2013-09-05

Publications (1)

Publication Number Publication Date
MX2021006716A true MX2021006716A (es) 2021-07-15

Family

ID=52628954

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016002922A MX2016002922A (es) 2013-09-05 2014-09-05 Metodos para la deteccion de enfermedad renal.
MX2021006716A MX2021006716A (es) 2013-09-05 2016-03-04 Metodos in vitro para la deteccion de enfermedad renal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016002922A MX2016002922A (es) 2013-09-05 2014-09-05 Metodos para la deteccion de enfermedad renal.

Country Status (20)

Country Link
US (2) US11035861B2 (es)
EP (3) EP3041576B1 (es)
JP (4) JP6657096B2 (es)
KR (2) KR102412431B1 (es)
CN (1) CN105705202B (es)
AU (2) AU2014315063B2 (es)
CA (2) CA2923140C (es)
CY (1) CY1123179T1 (es)
DK (1) DK3041576T3 (es)
ES (2) ES2969979T3 (es)
HR (1) HRP20191569T1 (es)
HU (1) HUE045723T2 (es)
LT (1) LT3041576T (es)
MX (2) MX2016002922A (es)
NZ (1) NZ717554A (es)
PL (1) PL3041576T3 (es)
PT (1) PT3041576T (es)
RS (1) RS59287B1 (es)
SI (1) SI3041576T1 (es)
WO (1) WO2015035155A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3041576T3 (pl) 2013-09-05 2019-12-31 Idexx Laboratories, Inc. Sposoby wykrywania choroby nerek
JP6896637B2 (ja) * 2015-02-20 2021-06-30 アイデックス ラボラトリーズ インコーポレイテッドＩＤＥＸＸ Ｌａｂｏｒａｔｏｒｉｅｓ， Ｉｎｃ． バックグラウンドシグナルを補正するホモジニアスなイムノアッセイ
CA2983943A1 (en) * 2015-04-30 2016-11-03 Idexx Laboratories, Inc. Methods for detecting renal disease
BR112019024907A2 (pt) 2017-05-31 2020-06-23 Mars, Incorporated Métodos de diagnóstico e tratamento de doença renal crônica
CN111033637B (zh) 2017-08-08 2023-12-05 费森尤斯医疗保健控股公司 用于治疗和评估慢性肾脏疾病的进程的系统和方法
WO2019079707A1 (en) * 2017-10-19 2019-04-25 Idexx Laboratories, Inc. SYMMETRIC DIMETHYLARGININE DETECTION
US20210373031A1 (en) * 2018-10-17 2021-12-02 Kagami Inc. Method for determining glomerular filtration ability
CN109545377B (zh) * 2018-10-22 2021-11-23 中南大学湘雅三医院 获取肾小球滤过率的模型的建立方法
US10745492B1 (en) * 2019-04-03 2020-08-18 Ark Diagnostics, Inc. Antibodies to symmetrically dimethylated arginine analytes and use thereof
WO2021046339A1 (en) * 2019-09-05 2021-03-11 The Regents Of The University Of California Noninvasive method to quantify kidney function and functional decline
EP4083628A4 (en) * 2019-12-27 2024-02-21 Kagami Inc. METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION
CN112768073B (zh) * 2021-01-15 2023-04-18 中山大学附属第三医院 一种肾小球滤过率估计模型的构建方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3134787A1 (de) 1981-09-02 1983-03-10 Boehringer Mannheim Gmbh, 6800 Mannheim Creatinin-antikoerper
US4818703A (en) 1985-10-23 1989-04-04 Pizzolante John M Stabilized alkaline picrate reagent for jaffe creatinine determination
EP0356160A3 (en) 1988-08-24 1991-09-11 The Board Of Trustees Of The Leland Stanford Junior University Capillary device
US5726010A (en) 1991-07-31 1998-03-10 Idexx Laboratories, Inc. Reversible flow chromatographic binding assay
US6455288B1 (en) 1993-04-08 2002-09-24 Dade Behring Marburg Gmbh Homogeneous immunoassays using mutant glucose-6-phosphate dehydrogenases
US5804452A (en) * 1995-04-27 1998-09-08 Quidel Corporation One step urine creatinine assays
AU7269098A (en) 1997-05-01 1998-11-24 Cooke Pharma, Inc. Cardiovascular disease risk assessment
US6736957B1 (en) 1997-10-16 2004-05-18 Abbott Laboratories Biosensor electrode mediators for regeneration of cofactors and process for using
US6358699B1 (en) 1999-02-05 2002-03-19 Cooke Pharma Assay for asymmetrical NG, NG dimethyl-l-arginine
WO2001046221A1 (en) 1999-12-22 2001-06-28 The Research Foundation Of State University Of New York Protein methylarginine-specific antibodies
CA2415174A1 (en) 2000-07-06 2002-01-17 Thomas W. Bell Methods and kits for the detection of arginine compounds
DE60133558D1 (de) * 2000-07-12 2008-05-21 Werner Naser Direkte bestimmung des quotients von analyt- zu referenzmolekülen
DE10040904A1 (de) 2000-08-18 2002-02-28 Boeger Rainer H Verfahren und Mittel zum Nachweis einer Wahrscheinlichkeit zukünftigen Fortschreitens von Gefässerkrankungen
US7241856B2 (en) 2003-06-02 2007-07-10 Pentron Clinical Technologies Llc Dental resins, dental composite materials, and method of manufacture thereof
JP4214271B2 (ja) 2002-10-15 2009-01-28 アークレイ株式会社 クレアチニン測定用試験片
US7501053B2 (en) 2002-10-23 2009-03-10 Abbott Laboratories Biosensor having improved hematocrit and oxygen biases
AU2003290784A1 (en) 2002-11-15 2004-06-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for detecting asymmetric dimethylarginine in a biological sample
US20050148029A1 (en) 2003-09-29 2005-07-07 Biosite, Inc. Methods and compositions for determining treatment regimens in systemic inflammatory response syndromes
ATE427497T1 (de) 2004-11-04 2009-04-15 Germediq Forsch & Entw Ges Mbh Methode zur bestimmung von arginin, methylierten argininen und deren derivate
US8736623B1 (en) 2004-11-15 2014-05-27 Nvidia Corporation Programmable DMA engine for implementing memory transfers and video processing for a video processor
WO2006078813A2 (en) 2005-01-21 2006-07-27 Biosite Incorporated Arginine analogs, and methods for their synthesis and use
JP2007176872A (ja) 2005-12-28 2007-07-12 Sentan Seimei Kagaku Kenkyusho:Kk アシンメトリックジメチルアルギニンを認識する抗体及びその製造方法並びに翻訳後修飾アミノ酸含有タンパク質の検出方法
FR2919063B1 (fr) * 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
US8628936B2 (en) * 2007-12-05 2014-01-14 King's College London Methods and compositions for multiplexed screening of disease
EP2313364B1 (en) 2008-08-07 2020-09-02 Idexx Laboratories, Inc. Methods for detecting symmetrical demethylarginine
RU2559569C2 (ru) * 2009-06-02 2015-08-10 Байокрейтс Лайф Сайенсиз Аг Новые биомаркеры для оценки болезней почек
CN101587118B (zh) * 2009-07-03 2012-09-12 长春迪瑞医疗科技股份有限公司 肌酐尿液分析试纸及制备方法
CN101598727B (zh) * 2009-07-09 2012-10-10 上海科华生物工程股份有限公司 定量测定人体血液尿素含量的干化学试纸
CN101865911A (zh) * 2010-03-16 2010-10-20 苏州市玮琪生物科技有限公司 一种尿肌酐定量检测卡
EP2612147B1 (de) 2010-11-17 2016-03-30 Karl-Heinz Kellner Automatenfähiger immunoassay für biogene amine
JP2012112785A (ja) 2010-11-24 2012-06-14 Tohoku Univ 透析膜の評価方法
JP5925026B2 (ja) * 2011-04-28 2016-05-25 アークレイ株式会社 クレアチニン測定用乾式試験片及びクレアチニン測定法
US20140038203A1 (en) * 2012-07-09 2014-02-06 Musc Foundation For Research Development Methods for detecting or predicting kidney disease
PL3041576T3 (pl) 2013-09-05 2019-12-31 Idexx Laboratories, Inc. Sposoby wykrywania choroby nerek

Also Published As

Publication number Publication date
KR102412431B1 (ko) 2022-06-22
AU2014315063B2 (en) 2020-07-23
EP3480600A1 (en) 2019-05-08
HUE045723T2 (hu) 2020-01-28
CA2923140A1 (en) 2015-03-12
ES2969979T3 (es) 2024-05-23
AU2020256440B2 (en) 2023-03-02
US20160187348A1 (en) 2016-06-30
KR20160051887A (ko) 2016-05-11
JP6657096B2 (ja) 2020-03-04
SI3041576T1 (sl) 2019-11-29
EP4295907A2 (en) 2023-12-27
KR102273028B1 (ko) 2021-07-02
EP3041576A4 (en) 2017-07-26
ES2746008T3 (es) 2020-03-04
PT3041576T (pt) 2019-09-27
EP4295907A3 (en) 2024-03-13
BR112016004839A8 (pt) 2020-02-11
MX2016002922A (es) 2016-11-07
AU2020256440A1 (en) 2020-11-12
DK3041576T3 (da) 2019-09-09
EP3041576A1 (en) 2016-07-13
HRP20191569T1 (hr) 2019-11-29
JP2016530532A (ja) 2016-09-29
CA2923140C (en) 2023-09-26
JP2022070879A (ja) 2022-05-13
CN105705202B (zh) 2019-02-26
US11035861B2 (en) 2021-06-15
PL3041576T3 (pl) 2019-12-31
JP2024020376A (ja) 2024-02-14
US20220137059A1 (en) 2022-05-05
AU2014315063A1 (en) 2016-03-17
EP3480600B1 (en) 2023-11-08
CN105705202A (zh) 2016-06-22
EP3041576B1 (en) 2019-06-19
EP3480600C0 (en) 2023-11-08
CY1123179T1 (el) 2021-10-29
LT3041576T (lt) 2019-10-25
JP2020073927A (ja) 2020-05-14
KR20210082567A (ko) 2021-07-05
NZ717554A (en) 2022-04-29
RS59287B1 (sr) 2019-10-31
CA3213810A1 (en) 2015-03-12
WO2015035155A1 (en) 2015-03-12

Similar Documents

Publication Publication Date Title
MX2021006716A (es) Metodos in vitro para la deteccion de enfermedad renal.
MX2021001694A (es) Sistemas y metodos para proporcionar recomendaciones de bienestar, nutricion y/o salud animal.
NZ749318A (en) System for monitoring pasture intake
BR112015022802A2 (pt) animal não-humano transgênico, progênie do animal, método para identificação de um composto, método para seleção da especificidade ou seletividade de ligação de um composto candidato, célula, tecido ou linhagem celular imortalizada, uso da célula, tecido ou linhagem celular imortalizada, método para identificação de um composto, método para filtragem da especificidade ou seletividade de ligação de um composto candidato, e uso de um composto de fórmula geral
WO2015191777A3 (en) Devices and methods for collecting and stabilizing biological samples
MX2016012133A (es) Determinacion de un indicador de riesgo de salud.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
DK3653049T3 (da) Polynukleotider, der koder for gnaverantistoffer med humane idiotyper, og dyr, der omfatter disse
FR3023617B1 (fr) Dispositif non invasif de determination de la fertilite et/ou du sexe d’un oeuf, et procede correspondant.
FR3036830B1 (fr) Systeme et methode pour l'estimation d'un volume de recolte au sein d'une exploitation viticole
BR112013030886A2 (pt) método, reagente e kit para medir hemoglobina glicada.
FR3030774B1 (fr) Procede de determination de parametres d'un filtre de compression et radar multivoies associe
BR112014015037A2 (pt) método, sistema e dispositivo eletrônico para determinar a trajetória de um fluxo aquoso, e sonda autônoma
BR112012028284A2 (pt) equipamento de insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de insensibilização de um animal para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um animal, método de manusear e processar um animal, método de abater um animal e equipamento para insensibilização de animais para induzir a inconsciência e a insensibilidade substancialmente imediatas permitindo o processamento ou manuseio de um anima
DE112013001973A5 (de) Verfahren und Vorrichtung zur akustischen Ermittlung der Gangart eines Huftieres, insbesondere Nutztieres
FR3018354B1 (fr) Procede d'analyse d'echantillons sedimentaires avec reconnaissance automatique de nannofossiles
WO2015002978A3 (en) Methods for rapid ribonucleic acid fluorescence in situ hybridization
MX2023007778A (es) Metodos para detectar enfermedad renal.
WO2016022614A8 (en) Method for evaluating health and genetic predisposition of animals
FR3028143B1 (fr) Dispositif de cloisonnement pour animaux, en particulier pour des veaux
FR3038091B1 (fr) Procede et dispositif de determination d'une permeabilite au sein d'un reservoir
DE112014001442A5 (de) Vorrichtung zur Vermessung eines Schlachttierkörperobjekts
MX2017010352A (es) Metodos para diagnosticar enfermedad valvular cronica.
TH1701000066A (th) ระบบและวิธีการสำหรับจัดให้มีคำแนะนำเกี่ยวกับสุขภาพโภชนาการ และ/หรือ ความสมบูรณ์แข็งแรงของสัตว์
FR3015847B1 (fr) Procede et dispositif d'estimation de parametres caracterisant un ensemble acoutisque